The Drug Information Association (DIA) will host the 22nd Annual Conference on Marketing Pharmaceuticals Integrated Marketing, Emerging Media Trends, and New Regulations from February 22-24 in New York, NY.
This annual pharma marketing conference will provide insight into emerging media trends and how they impact FDA enforcement actions. Experts from industry and FDA will discuss the evolution of the regulatory and legal environment and how this new environment impacts the marketing of biopharmaceuticals and related products. Session topics will include:
- Enforcement by the three centers within FDA that regulate drugs
- Biological products and veterinary drugs
- Direct-to-consumer advertising
- State regulations
- Oversight of off-label issues by the Office of Inspector General and Department of Justice
- Latest innovations in the use of the internet for product
Rachel E. Behrman, MD, MPH, Deputy Director, Office of Medical Policy; Associate Commissioner for Clinical Programs, will deliver a keynote address the future initiatives of the Office of Medical Policy.
A half-day pre-conference tutorial, DDMAC and Compliance 101: A Primer, will take place on February 22.
ABOUT THE DRUG INFORMATION ASSOCIATION (DIA)
DIA is a neutral, global, professional, member-driven association of nearly 18,000 biotechnology, pharmaceutical, academic, and regulatory professionals. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.
Contact: Joe Krasowski